Metacrine, Inc. Common Stock
MTCR
MTCR was delisted on the 8th of February, 2023.
35 hedge funds and large institutions have $37.9M invested in Metacrine, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 11 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.53% less ownership
Funds ownership: 47.2% → 41.67% (-5.5%)
17% less funds holding
Funds holding: 42 → 35 (-7)
20% less capital invested
Capital invested by funds: $47.4M → $37.9M (-$9.47M)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
+$861K |
| 2 |
Renaissance Technologies
New York
|
+$634K |
| 3 |
Two Sigma Advisers
New York
|
+$271K |
| 4 |
Two Sigma Investments
New York
|
+$183K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$150K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$2.95M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$2.38M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.19M |
| 4 |
Millennium Management
New York
|
-$224K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$212K |
MTCR Hedge Fund Activity: Q3 2021 in Review
35 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q3 2021, worth a combined $37.9M — down 20% from $47.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of MTCR and 4 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 12 added.
The largest buyer was Prosight Management, adding an estimated $861K. The largest seller was Franklin Resources, cutting an estimated $2.95M.
- 35 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q3 2021, down from 42 in Q2 2021.
- Funds reported $37.9M of Metacrine, Inc. Common Stock stock for Q3 2021, down 20% quarter-over-quarter.
- 4 funds opened new Metacrine, Inc. Common Stock positions in Q3 2021 and 11 closed out, a net change of -7 holders.
- The largest Metacrine, Inc. Common Stock buyer in Q3 2021 was Prosight Management, an estimated $861K added.
- The largest Metacrine, Inc. Common Stock seller in Q3 2021 was Franklin Resources, an estimated $2.95M sold.
Based on aggregated 13F filings for Q3 2021.